Sun Pharma Advanced Research Company Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 12.90 | 18.37 | 20.96 |
| Operating Expense | 116.71 | 111.93 | 124.08 |
| Net Profit | -107.69 | -96.84 | -106.69 |
| Net Profit Margin | -834.81 | -527.16 | -509.02 |
| Earning Per Share | -3.32 | -2.98 | -3.29 |
| EBIDTA | -103.81 | -93.56 | -103.12 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 12.90 |
| Operating Expense | 116.71 |
| Net Profit | -107.69 |
| Net Profit Margin | -834.81 |
| Earning Per Share | -3.32 |
| EBIDTA | -103.81 |
| Effective Tax Rate | TBA |
Invest in Sun Pharma Advanced Research Company Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 75.55 | 238.78 | 137.25 |
| Operating Expenses Annual | 479.34 | 452.84 | 324.00 |
| Operating Profit Annual | -374.32 | -203.18 | -179.90 |
| Interest Annual | 1.66 | 7.63 | 13.33 |
| Depreciation | 12.13 | 11.77 | 10.16 |
| Net Profit Annual | -388.11 | -222.58 | -203.40 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 75.55 |
| Operating Expenses Annual | 479.34 |
| Operating Profit Annual | -374.32 |
| Interest Annual | 1.66 |
| Depreciation | 12.13 |
| Net Profit Annual | -388.11 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.58 | 1.22 | 9.30 |
| Cash Flow from Operations | -429.43 | -69.12 | -208.23 |
| Cash Flow from Investing | 391.11 | -548.28 | -29.17 |
| Cash Flow from Financing | 42.80 | 616.76 | 229.32 |
| Cash Flow at the End | 5.06 | 0.58 | 1.22 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.58 |
| Cash Flow from Operations | -429.43 |
| Cash Flow from Investing | 391.11 |
| Cash Flow from Financing | 42.80 |
| Cash Flow at the End | 5.06 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -495.46 | -85.09 | -131.07 |
| PBIT Margin (%) | -511.52 | -90.02 | -138.48 |
| PBT Margin (%) | -203.38 | -78.22 | -128.09 |
| Net PROFIT Margin (%) | -513.71 | -93.22 | -148.20 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -82.19 | -53.13 | -133.38 |
| Total Debt / Equity (X) | 0.11 | 0.17 | TBA |
| Asset Turnover Ratio (%) | 0.16 | 0.57 | 0.90 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -495.46 |
| PBIT Margin (%) | -511.52 |
| PBT Margin (%) | -203.38 |
| Net PROFIT Margin (%) | -513.71 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -82.19 |
| Total Debt / Equity (X) | 0.11 |
| Asset Turnover Ratio (%) | 0.16 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 145.17 | 130.88 | 114.51 |
| Total Current Assets Annual | 246.41 | 454.96 | 71.15 |
| Non Current Assets Annual | 239.93 | 375.16 | 208.93 |
| Total Shareholders Funds Annual | 124.86 | 512.78 | 31.23 |
| Total Assets Annual | 486.33 | 830.13 | 280.08 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 145.17 |
| Total Current Assets Annual | 246.41 |
| Non Current Assets Annual | 239.93 |
| Total Shareholders Funds Annual | 124.86 |
| Total Assets Annual | 486.33 |
EPS (INR)
Expected
0.00
Reported
-3.31
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
